abstract: This study assessed the participation of amphiregulin (AREG) and bone morphogenetic protein 15 (BMP15) during maturation of bovine cumulus-oocyte complexes (COCs) on cumulus cell function and their impact on subsequent embryo development. AREG treatment of COCs enhanced blastocyst formation and quality only when in the presence of BMP15. Expression of hyaluronan synthase 2 was enhanced by follicle-stimulating hormone (FSH) but not by AREG, which was reflected in the level of cumulus expansion. Although both FSH and AREG stimulated glycolysis, AREG-treated COCs had higher glucose consumption, lactate production and ratio of lactate production to glucose uptake. Autofluorescence levels in oocytes, indicative of NAD(P)H and FAD ++ , were increased with combined AREG and BMP15 treatment of COCs.
Introduction
Oocytes from in vitro maturation (IVM) have reduced developmental competence in clinical settings. To improve IVM outcomes and hence the clinical update of the procedure, understanding of the mechanisms regulating oocyte developmental competence and how these are impacted by IVM is imperative.
Complex cellular processes occur during oocyte maturation within the ovarian follicular environment that determine the oocyte's developmental competence, defined as the capacity of the oocyte to support fertilization and early embryo development . Significantly, this underpins fetal and neonatal development, postnatal health and prevention of programmable diseases Mtango et al., 2008) . Oocyte maturation is coordinated by follicular cells, including granulosa and cumulus cells. These respond to stimulation by gonadotrophins (luteinizing hormone (LH) and follicle-stimulating hormone (FSH)), which in turn interact with a complex array of local growth factors. How these signaling processes within the somatic cell compartment of the ovarian follicle endow the oocyte with developmental competence is a subject of intensive research, as these processes set the life course of healthy development and provide opportunities for clinical interventions to treat infertility.
Oocyte maturation occurs during the period between the LH surge and ovulation. LH, via the cyclic adenosine 3 ′ ,5 ′ -monophosphate (cAMP)-dependent pathway, induces a rapid and transient expression of epidermal growth factor (EGF)-like factors amphiregulin (AREG), epiregulin (EREG) and betacellulin (BTC), which are ligands for the EGF receptor (EGFR) as well as other members of the ErbB family in both mural granulosa and cumulus cells, thereby inducing maturation of the cumulus-oocyte complex (COC) (Park et al., 2004; Shimada et al., 2006; Hsieh et al., 2007) . EGF-like factors are also produced by cumulus cells upon stimulation with FSH in vitro, where they trigger resumption of meiosis (Downs and Chen, 2008) . During the maturation of COCs, extracellular signal-regulated kinases 1 and 2 (ERK1/2), phosphoinositide 3-kinase (PI3K)/Akt and p38 mitogen-activated protein kinase (p38 MAPK) have been identified as downstream effectors of EGFR signaling in cumulus cells following ligand binding (Shimada et al., 2006; Yamashita et al., 2007; Prochazka et al., 2012) . Furthermore, EGF-like factors stimulate gene expression in cumulus cells that enable the production of hyaluronic acid and its organization within the extracellular matrix. Together, these promote modification and expansion of COCs which is essential for ovulation, but not for oocyte developmental competence.
Oocyte-secreted factors (OSFs) such as bone morphogenetic protein 15 (BMP15) (Laitinen et al., 1998) and growth differentiation factor 9 (GDF9) (Dong et al., 1996) , which are members of the transforming growth factor beta (TGF-b) superfamily, are required for correct differentiation of cumulus cells which is crucial for normal oocyte maturation (Eppig, 2001; Gilchrist et al., 2006) . OSFs regulate proliferation (Li et al., 2000) , gene expression (Paradis et al., 2010; Regassa et al., 2011) , luteinization (Eppig et al., 1997) , apoptosis (Hussein et al., 2005) and expansion of the extracellular matrix within cumulus cells. In the mouse, GDF9 and BMP15 regulate EGFR expression in cumulus cells (Su et al., 2010) . Furthermore, in granulosa and cumulus cells, GDF9 requires the activation of EGFR-ERK1/2 signaling (Sasseville et al., 2010) , suggesting that oocyte paracrine signals work cooperatively with EGFR signaling to regulate the function of follicular cells in the somatic compartment of the follicle.
Previous studies have indicated that FSH, AREG and EREG enhance oocyte developmental competence (Prochazka et al., 2011; Demeestere et al., 2012; Richani et al., 2013) . Interestingly, COCs cultured with EGF-like factors have higher developmental competence compared with those cultured with gonadotrophins such as FSH, LH and equine chorionic gonadotrophin (Prochazka et al., 2011; Richani et al., 2013) .
Bmp15 and/or Gdf9 null mice exhibit reduced fertility, at least in part due to impaired functions of granulosa cells and lower developmental competence of oocytes . In addition, we have demonstrated that supplementation of recombinant BMP15 or GDF9 during IVM of COCs significantly improves oocyte developmental competence, as assessed by increased blastocyst and fetal yield and blastocyst cell number (Hussein et al., 2006; Yeo et al., 2008) . This may be related to the observation that, in the mouse at least, IVM oocytes are deficient in processed BMP15, relative to in vivo matured oocytes (unpublished data).
Gonadotrophins and OSFs also regulate some of the metabolic processes that occur within follicular cells to support oocyte maturation. FSH stimulates glucose uptake by PI3K-mediated translocation of glucose transporter 4 protein to the membrane of granulosa cells (Roberts et al., 2004) . Endogenous OSFs control amino acid uptake (Eppig et al., 2005) , cholesterol biosynthesis (Su et al., 2008) and glycolysis in cumulus cells (Sugiura et al., 2007) . These processes are important for metabolite supply to the oocyte, which may be mediated via cumulus-oocyte gap junctions that are regulated by FSH (Sommersberg et al., 2000) as well as by local paracrine signals.
In the present study, our aim was to investigate the mechanisms underpinning how EGF-like factors and OSFs act together to regulate bovine oocyte developmental competence. First, we examined the effect of AREG in the presence of native OSFs and the recombinant OSFs, human GDF9 and human BMP15, on oocyte meiotic maturation, in vitro development and blastocyst cell number. Our results indicate that AREG co-operates with BMP15 to enhance oocyte developmental competence. To gain further understanding of the improved oocyte developmental competence, we examined the effect of AREG and BMP15 on cumulus cell expansion; cumulus cell expression of transcripts encoding proteins such as hyaluronic acid 2 (HAS2), tumor necrosis factor alpha-induced protein 6 (TNFAIP6), pentraxin 3 (PTX3) and prostaglandin-endoperoxide synthase 2 (PTGS2); COC metabolism such as glycolysis and levels of autofluorescence within the oocyte, indicative of the metabolic co-enzymes reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and oxidized flavin adenine dinucleotide (FAD ++ ). The effect of AREG and BMP15 on gap-junctional communication (GJC) between cumulus cells and the oocyte was also assessed.
Materials and Methods

Chemicals and culture media
Unless specified, chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). Oocyte IVM medium was bicarbonate buffered TCM 199 (B-199, ICN Biochemicals, Irvine, CA, USA) supplemented with 4 mg/ml of fatty-acid free bovine serum albumin (FAF-BSA; ICP biological; Auckland, New Zealand), 0.5 mM pyruvate and kanamycin sulfate (0.1 mg/ml). Wash medium was VitroWash (IVF Vet Solutions, Adelaide, SA, Australia) plus 4 mg/ml of FAF-BSA. In vitro fertilization (IVF) medium was VitroFert (IVF Vet Solutions) plus 4 mg/ml FAF-BAS. Embryo cleavage and blastocyst media were VitroCleave (IVF Vet Solutions) plus 4 mg/ml FAF-BSA and VitroBlast (IVF Vet Solutions) plus 4 mg/ml FAF-BSA, respectively.
Oocyte collection and IVM
Collection and IVM of bovine COCs was performed as previously described (Sutton-McDowall et al., 2012) . Bovine ovaries from a slaughterhouse were transferred to the laboratory, and then washed and stored in physiological saline at 38.58C. COCs were aspirated from small follicles (2 -6 mm in diameter) using a 10-ml syringe equipped with an 18-gauge needle and collected in HEPES-buffered tissue culture medium 199 (HEPES-buffered TCM199; ICP biological) supplemented with 4 mg/ml of FAF-BSA. Compact COCs with .3 layers of cumulus cells and a homogeneous ooplasm were washed twice with HEPES-TCM 199. COCs were cultured in IVM medium without ligand addition (control), with 0.1 IU/ml FSH (Puregon; Organon, Oss, The Netherlands) (FSH), or with 100 ng/ml recombinant human amphiregulin (AREG; R&D systems, Minneapolis, MN, USA) in the presence or absence of denuded oocytes (Dos) (0.5 oocyte/ml), 100 ng/ml of human GDF9 or 100 ng/ml of human BMP15. GDF9 and BMP15 were produced in our laboratory as concentrated preparations of the pro-and mature-region complexes, produced in 293T cells, as previously described (Pulkki et al., 2011 (Pulkki et al., , 2012 . Ten COCs were incubated in 100 ml of IVM medium, covered with paraffin oil in 35-mm Petri dishes at 38.58C for 22 h in a humidified atmosphere with 6% CO 2 in air. About 20 COCs were used per treatment per replicate.
Assessment of meiotic status
Following IVM for 22 h, COCs were mechanically denuded by pipetting and then fixed using 4% paraformaldehyde for 1 h at 48C. Fixed oocytes were incubated in a permeating solution (0.5% triton X-100 and 0.5% sodium citrate) for 15 -30 min, followed by incubation in 3 mM 4 ′ ,6-diamidino-2-phenylindole solution in the dark for 15 min. Oocytes were washed in phosphate-buffered saline containing 1 mg/ml BSA and then mounted on a slide with glycerol. Chromosome configurations were assessed using a Nikon Eclipse TE2000-E microscope (330-380 nm excitation wavelength; Nikon, Melville, NY, USA).
In vitro embryo production
In vitro embryo production was performed as previously reported (Hussein et al., 2006) . Briefly, following IVM, COCs were washed once with wash media and once with IVF medium. Frozen sperm samples (0.5 ml) were thawed at 378C for 30 s and then centrifuged in a discontinuous Percoll (GE Healthcare, Piscataway, NJ, USA) gradient (45%:90%) at 271g for 25 min. The pellet was then resuspended in wash medium and centrifuged at 56g for 5 min. Spermatozoa were resuspended in IVF medium, and 20 ml of this suspension was added to 380 ml IVF medium containing COCs to yield a final concentration of 1 × 10 6 sperm/ml. After 20 h of culture (Day 1), putative zygotes were mechanically denuded from cumulus cells and spermatozoa by gently pipetting using a glass pipette. A total of five zygotes were placed in a droplet of 20 ml of cleavage medium and cultured at 38.58C in 6% CO 2 , 7% O 2 , nitrogen balance. On Day 5 of culture, embryos were transferred into blastocyst medium. The rates of cleavage and blastocyst formation were calculated on Day 2 and Days 7 and 8, respectively.
Differential staining of blastocyst inner cell mass and trophectoderm cells
The allocation of cells within blastocysts was assessed by differential staining of ICM and TE cells as described previously (Hardy et al., 1989) . Briefly, the zona-pellucida was removed using 0.5% pronase at 378C. Embryos were washed in wash medium minus protein and cultured in 10% 2,4,6-trinitrobenzene sulfonic acid for 10 min at 48C in the dark. Embryos were then incubated in anti-2,4-dinitrophenol (1:10) for 10 min at 378C, followed by a 10-min incubation in complement (2 mg/ml of propidium iodine:-guinea pig serum 1:1). Embryos were then fixed in ethanol containing 25 mg/ ml Hoechst 33342. Fixed and stained embryos were mounted in 100% glycerol, and the number of ICM and TE cells was assessed under an epifluorescence microscope (excitation ¼ 340-380 nm and emission ¼ 440 -480 nm). ICM and TE nuclei appear blue and pink, respectively.
COCs expansion assay
Cumulus expansion was assessed according to the scoring system of Vanderhyden et al. (1990) . Briefly, a score of 0 indicates no detectable response; +1 indicates minimum response, with cells in the peripheral two layers beginning to expand; +2 indicates expansion extending inwards to several layers; +3 indicates expansion of all layers of cumulus except the corona radiata cells; and +4 indicates expansion of the entire cumulus including corona radiata cells. Cumulus expansion was examined at 3, 6, 12 and 22 h of IVM.
RNA extraction and real-time RT -PCR analysis
HAS2, TNFIPA6, PTX3 and PTGS2 genes were analyzed by real-time PCR as previously described (Gilchrist and Ritter, 2011) . Ribosomal protein L19 (RPL19) was used as the endogenous control, as this was found to be stably expressed regardless of the experimental treatments. COCs cultured for 3, 6, 12 and 22 h were mechanically stripped of their cumulus cells by vigorous pipetting using a 200 ml pipette. Cumulus cells from 30 COCs were lysed in 300 ml of RTL buffer containing 10 ml/ml of 2-mercaptoethanol and stored at 2808C until RNA extraction. Total RNA was extracted from each sample using the RNeasy Micro Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer's instructions and quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific, Scoresby, VIC, Australia). Residual genomic DNA was removed by digesting with recombinant RNase-free DNase I (QIAGEN). RNA (200 ng) was reverse transcribed with random primers (Invitrogen) using Super-Script III (Invitrogen Australia Pty Limited, Mount Waverley, Australia). Quantitative real-time PCR analysis was performed on a Corbett Rotor-Gene 6000 (QIAGEN) in a 20-ml reaction volume containing 3 ml cDNA, 2.5 ml each of forward and reverse primers (Table I) , that were designed from bovine sequences, 2 ml nucleasefree water and 10 ml SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). All PCR reactions were carried out in duplicate. Universal thermal cycling parameters (initial step of 2 min at 508C and 10 min at 958C, followed by 40 cycles of 15 s at 958C and 60 s at 608C) were used to quantify the expression of all genes. At the end of the real-time PCR analysis, melting curve analysis was carried out on the real-time cycler to check the specificity of the reaction. A standard curve was generated for the gene of interest and for the endogenous control gene (RPL19) in every PCR run by using a serial 5-fold dilution of the amplified cDNA derived from cumulus cells. Final quantitative analysis of each gene was performed using the standard curve method and results were reported as a relative to the housekeeping gene RTL19.
Glucose and lactate metabolism
Glucose uptake and lactate production by COCs were determined by measuring the concentration of each substrate in the spent media as previously described ( Gene name GenBank accession number Primer sequences forward (F) and reverse (R) Amplicon size (bp)
Participation of AREG and BMP15 in COCs media samples were snap frozen and stored at 2808C. Glucose and lactate concentrations in 50 ml of spent media were determined using a Hitachi 912 chemical analyzer (F. Hoffmann-La Roche Ltd; Basal, Switzerland) and 10 media samples (10 COCs per 100 ml) were measured for each treatment. Glucose uptake and lactate production were expressed as pmol COC 21 h 21 .
Redox state
Redox state in the oocyte was determined following measurement of autofluorescence emissions that relate to the concentration of NAD(P)H and FAD ++ , using methodologies previously described and validated (Dumollard et al., 2004) . After 22 h of culture, COCs were denuded by gentle pipetting using a 200 ml pipette. Oocytes were washed twice in wash medium and transferred into 5 ml of wash medium overlaid with mineral oil in glass bottom confocal dishes (Cell E & G; Houston, TX, USA). Laser intensity for autofluorescence detection (excitation: 405 nm, emission: 420 -520 nm) and green (excitation: 473 nm, emission: 490 -590 nm) was set at 50% maximal power and detection sensitivity was 75% (blue) and 65% (green), respectively. Images were captured at ×40 magnification, 521 × 521 pixel image size and 8× speed/quality by using an Olympus Fluoview FV10i confocal microscope (Olympus; Tokyo, Japan). Microscope and image settings remained constant throughout. Fluorescence intensity was measured with the FV10-ASW 3.0 software (Olympus). The intensity was normalized to the mean value of the background excluding oocytes in each photograph. Autofluorescence was also assessed in oocytes which were matured in groups of 10 denuded oocytes (DOs) or 5 DOs co-cultured with 5 COCs.
Gap junctional communication assay
The degree of gap junction communication in COCs was assessed using lucifer yellow (LY) dye microinjected into the ooplasm, as previously described (Luciano et al., 2004) . After 0, 3, 6 and 12 h of IVM, 3% LY in 5 mM lithium chloride was microinjected into the oocyte. The spread of dye into the surrounding cumulus cells was assessed with the confocal microscope within 15 min of injection. As a positive control, the coupling of COCs was assessed immediately after collection, and as a negative control, COCs were cultured in IVM medium for 12 h supplemented with the gap-junction inhibitor, carbenoxolone (CBX, 100 mM) and assessed at 12 h. Individual COCs were scored as +2 when the dye was completely transferred to the entire cumulus mass, +1 when the dye was transferred to limited number of cumulus cell layers just beyond the corona radiata and 0 when the dye was transferred to only the corona radiata cells or was not transferred to any cumulus cells at all (Fig. 6A) . The average score of 10 COCs in each treatment group was calculated to generate the GJC coupling index.
Statistical analysis
Data were analyzed using analysis of variance (ANOVA) followed by TukeyKramer test or Student t-test. All percentage data were arcsine transformed prior to ANOVA. For all data, P , 0.05 was considered significant. All analyses were conducted using StatView (SAS Institute, Inc., NC, USA). 
Results
Amphiregulin enhances oocyte developmental competence in the presence of exogenous OSFs
The effect of AREG and FSH during the COC maturation phase in vitro on oocyte meiotic progression and subsequent embryo development were examined, firstly alone and then in the presence of native OSFs (denuded oocytes; DOs), recombinant GDF9 and BMP15 in their pro-mature form. Regardless of the presence or absence of native or recombinant OSFs, AREG and FSH supplementation did not affect the resumption and completion of oocyte nuclear maturation (Supplementary data, Fig. S1 ). Post fertilization, there were no significant differences in embryo cleavage rates or the proportion of pre-compaction embryos across all treatments (P . 0.05; Fig. 1 ). In the absence of native or recombinant OSFs (Fig. 1A) , FSH increased total blastocyst development 1.6-fold on Day 8 (on time development) compared with the control, whereas AREG did not influence total blastocyst development on either Day 7 or 8. However, treatment of oocytes during maturation with AREG and with either DOs or BMP15 further increased total blastocyst development on both Days 7 and 8, compared with the control group (P , 0.05; Fig. 1B and D) . This additive effect of OSF and AREG enhancing preimplantation embryo development was not observed when GDF9 was added during oocyte maturation (Fig. 1C) .
The FSH and AREG treatment groups had significantly higher rates of hatching/hatched blastocysts compared with the control group, in absence of OSFs (Fig. 1A) .
Cell allocation to the inner cell mass cell lineage (ICM; fetal progenitor) or trophectoderm (TE; placenta progenitor cells) within blastocysts is an indicator of embryo health and predicts post-implantation embryo and fetal developmental potential (Sugimura et al., 2012) . In the absence of OSFs, there was no difference in the number of ICM and TE cells between the various experimental groups (P . 0.05; Fig. 2A ). In contrast, the number of total and ICM cells in the subsequent blastocysts was significantly increased in the groups supplemented with AREG and DOs (Fig. 2B) or BMP15 (Fig. 2D) during the oocyte maturation phase, but not in the FSH group. As with embryo development, supplementation with GDF9 + FSH or GDF9 + AREG had no influence on embryo quality as assessed by ICM, TE and total cell numbers within blastocysts (Fig. 2C) .
Regulation of cumulus cell expansion by amphiregulin, FSH and BMP15
Cumulus cell production of extracellular matrix proteins is a hallmark of the ovulatory cascade, and expression of some of the related genes are among the most reliable markers of oocyte developmental competence (Adriaenssens et al., 2010; Wathlet et al., 2011) . We measured cumulus expansion and expression of relevant genes within cumulus cells of COCs treated with either FSH or AREG, with and without BMP15 (Figs 3 and 4) . As expected, cumulus expansion was observed from 12 h of oocyte maturation in both FSH-and AREG-treated groups (Fig. 3A) . Overall, BMP15 did not promote morphological cumulus expansion or expression of any matrix gene, nor affect the capacity of FSH or AREG to do so ( Fig. 4B -E) . The level of expansion in AREG-treated COCs was 80% of the FSH group at 22 h (P , 0.05), and was not improved by the addition of BMP15 (Fig. 4A) . FSH stimulated higher HAS2 expression than AREG, with maximum expression observed at 6 and 12 h of oocyte maturation (Fig. 3B) . Consistent with the morphological measures of cumulus cell expansion, AREG did not alter cumulus cell HAS2 gene expression at any stage during COC maturation (Fig. 3B) . TNFAIP6 expression within cumulus cells of the FSH-treated group was higher at 3 h than in the AREG-treated group (P , 0.05; Fig. 3C ).
Furthermore, cumulus cells of FSH-treated COCs at 22 h had higher TNFAIP6 expression compared with control, and although this response was not achieved with AREG alone, it was with AREG combined with BMP15 (Fig. 4C) . The expression level of PTX3 was significantly higher following 3 h of oocyte maturation in the FSH-stimulated group, but otherwise no difference was observed at any other time point (Fig. 3D) . In both FSH-and AREG-stimulated groups, PTGS2 expression increased from 12 to 22 h (Fig. 3E) . Expression level of PTGS2 at 22 h did not differ with FSH or AREG stimulation (Fig. 4E) . These results demonstrate that the slightly diminished cumulus cell expansion observed within the AREG-stimulated COCs correlated with less expression of extracellular matrix-related genes, most notably an absence of change in HAS2 expression. (A) CEI in COCs cultured with no ligand (control), FSH or AREG in the presence or absence of BMP15 was examined at 22 h of oocyte maturation. Values are represented as mean + SEM of four replicates. Different letters indicate significant differences at P , 0.05. Expression of HAS2 (B), TNFIPA6 (C), PTX3 (D) and PTGS2 (E) in cumulus cells of COCs cultured with no ligand (control), FSH or AREG in the presence or absence of BMP15 were examined at 22 h of oocyte maturation. Control group in the absence of BMP15 was assigned a value of one and all other points are expressed relative to this point. Values are represented as mean + SEM of four replicates. Different letters indicate significant differences at P , 0.05.
Participation of AREG and BMP15 in COCs
Amphiregulin stimulates cumulus-oocyte complex glycolysis
Within the COC, glucose is mostly metabolized to lactate via glycolysis for energy production and this primarily occurs within the cumulus cell compartment of the complex (Sutton-McDowall et al., 2010) . Glucose uptake, lactate production and lactate:glucose ratio were measured in COCs cultured with FSH or AREG in the presence or absence of BMP15 (Fig. 5) . Theoretically, under conditions that enable complete glycolysis, two molecules of lactate are produced from one glucose molecule; hence the lactate:glucose ratio can indicate the proportion of glucose metabolized via glycolysis, as opposed to other metabolic fates of glucose. Overall, AREG stimulated COC glycolysis to a greater extent than FSH, as evidenced by higher levels of glucose consumption and lactate production ( Fig. 5A and B) . BMP15 had no appreciable effect on COC glycolysis, although the combination of BMP15 and AREG stimulated more glucose consumption than those treated with FSH (P , 0.05; Fig. 5A ). The ratio of lactate production to glucose uptake was significantly higher in AREG-treated COCs than in FSH-treated COCs, and the lactate:glucose ratio was also increased (AREG + BMP v FSH + BMP) with the addition of BMP15 (P , 0.05; Fig. 5C ). These results indicate that AREG stimulation of oocyte maturation results in a higher glycolytic activity compared with FSH-stimulation.
NAD(P)H and FAD
11 in oocytes is increased by the combination of AREG and BMP15 and requires cumulus cell-oocyte contact
Monitoring oocyte autofluorescence of NAD(P)H and FAD
++ provides information about oocyte metabolism and cellular REDOX state (Dumollard et al., 2007) . When oocytes were treated as intact COCs with the combination of BMP15 plus AREG, intra-oocyte NAD(P)H and FAD ++ levels were significantly increased, compared with the control group without BMP15 (COCs; Fig. 6 Fig. 6 , A2 -C2). Similarly, these measures were unchanged in denuded oocytes that were exposed from the start of culture to intact COCs (DOs+COCs; Fig. 6 , A3 -C3), suggesting that a metabolic difference in COCs caused by the ligand treatments could not be transmitted by paracrine means to neighboring denuded oocyte in culture. These results suggest that the elevated levels of intra-oocyte NAD(P)H and FAD ++ , caused by incubation in media supplemented with AREG and BMP15, requires the coupling of oocytes to cumulus cells, and is not the result of a direct action of the ligands on oocytes or paracrine secretions by cumulus cells to oocytes.
BMP15 sustains cumulus-oocyte gap-junctional communication
Because metabolic co-enzymes levels were increased in oocytes within intact COCs following treatment with AREG and BMP15, but not within denuded oocytes (Fig. 6) , we next investigated the role of AREG and BMP15 in intercellular coupling of cumulus cells with oocytes by injecting lucifer yellow dye into the ooplasm (Fig. 7) . Diffusion of the dye from the oocyte into cumulus cells is a standard measure of oocyte-CC GJC (Wert and Larsen, 1989) . Prior to maturation (Fig. 7A) The coupling index at 3 and 6 h was significantly higher in groups treated with FSH and FSH+AREG than in the control and those treated with AREG (Fig. 7B) . Levels of coupling in FSH and FSH+AREG groups remained steady until 3 h of oocyte maturation, unlike in the control and AREG groups, indicating that AREG could not maintain oocyte-CC GJC to levels maintained by FSH. No significant differences were observed among the experimental groups at 12 h, nor with COCs treated with the gap junction inhibitor carbenoxolone (CBX), indicating that oocyte-CC GJC in all groups was completely closed at 12 h of maturation. In the presence of BMP15 for 3 h, coupling indexes in the control and AREG groups were not different from that of the FSH group (Fig. 7C ) and were similar to levels at 0 h. By 6 h of oocyte maturation, oocyte-CC coupling was sustained by FSH or by BMP15 alone or in combination with FSH or AREG. Taken together these results indicate that BMP15 has the capacity to sustain oocyte-CC GJC during oocyte maturation.
Discussion
The means by which oocytes acquire and maintain developmental competence is an extraordinarily complex, yet a fundamentally important biological process, as it sets the developmental life course for the ensuing embryo, fetus and offspring. During oocyte maturation in vivo and in reproductive medicine, where immature oocytes are removed from ovarian follicles and cultured as intact COCs prior to fertilization, hormones and growth factors control the fundamental processes of oocyte maturation (Gilchrist and Ritter, 2011) . Previous studies in various animal models have shown that COCs cultured with either EGF-like factors (such as AREG and EREG (Prochazka et al., 2011; Richani et al., 2013) ) or OSFs (Hussein et al., 2006) have increased oocyte developmental competence. This is consistent with emerging critical roles of OSFs in regulating cumulus cell differentiation and EGF-like factors mediating the endocrine ovulatory signal in the ovarian follicle (Conti et al., 2006) . However, our understanding of how EGF-like factors and OSFs may work together to regulate oocyte competence is limited. Here we demonstrate that AREG Figure 6 Regulation of oocyte reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H), oxidized flavin adenine dinucleotide (FAD ++ ) and redox ratio by ligands and cumulus-oocyte contact. Intensity of oocyte autofluorescence of NAD(P)H (A1 -A3) and FAD ++ (B1-B3) and the redox ratio (C1-C3) in oocytes that were cultured 0-22 h as intact COCs (COCs; A1 -C1), or cultured 0 -22 h as denuded oocytes (DOs; A2 -C2), or cultured 0 -22 h as denuded oocytes in co-culture with COCs (DOs+COCs; A3 -C3). All cultures were treated with no ligand (control), FSH or AREG, in the presence or absence of BMP15. Within each graph, the control group in the absence of BMP15 was assigned a value of one and all other means are expressed relative to this value. Values are represented as mean + SEM of five replicates. Different letters indicate significant differences at P , 0.05.
works cooperatively with BMP15 to enhance oocyte developmental competence, possibly by increasing the metabolite supply from the cumulus cells to the oocyte through extended gap-junction coupling. As summarized in Table II , in the absence of any exogenous OSFs, both FSH and AREG during the oocyte maturation phase improved the hatching capacity of blastocysts. However, blastocyst formation could only be enhanced by FSH and not by AREG. In contrast, in the presence of either native OSFs (co-cultured DOs) or BMP15, AREG-treated COCs showed enhanced preimplantation development to the blastocyst stage, with increased blastocyst ICM numbers, compared with FSH-treated COCs. This suggests that AREG works cooperatively with exogenous OSFs such as BMP15 to enhance oocyte developmental competence and via a different mode of action to that of FSH. In addition, these results have important practical implications for the treatment of human infertility and for advanced domestic animal breeding, as they suggest that the addition of either native or recombinant OSFs is more efficacious in AREG-stimulated oocyte maturation than in the current universal practice of FSH-stimulated oocyte maturation.
Numerous studies have now shown that native or recombinant OSFs, when added to IVM, enhance mammalian oocyte developmental competence. This suggests that the secretion or availability of resident OSFs from within the IVM COC is aberrant or deficient in some manner. In support of this, we have recently found that IVM mouse COCs, but not in vivo matured COCs, lack the processed form of BMP15 (Gilchrist et al; unpublished data) , and that recombinant mouse GDF9 (in pro-mature complex form) improves mouse oocyte competence in the presence of FSH (Yeo et al., 2008) . Unlike most members of the TGFb superfamily, there are marked species-specific differences in the expression and bioactivity of GDF9 and BMP15 ligands. For example, the pro-mature complex of human GDF9, but not mouse GDF9, is naturally latent and requires dissociation of the pro-mature complex for biological activity (Mottershead et al., 2008; Simpson et al., 2012 ). In the current study, we used human GDF9 and BMP15 proteins, as the bovine growth factors are not yet available and the human proteins are most relevant to future human applications. Moreover, as the species-specific expression and activity of these proteins is related to, or potentially determines, natural mammalian ovulation rate (McNatty et al., 2005; Crawford and McNatty, 2012) , human (c.f. murine) variants of GDF9 and BMP15 proteins are currently most relevant for bovine studies, as both species tend to be mono-ovular. Human GDF9 in the pro-mature form had little effect on oocyte competence (current study). This suggests that neither FSH-or AREG-stimulated COCs are capable of activating latent human GDF9.
Cumulus cell expansion, which plays a key role in normal fertilization (Fulop et al., 2003) , involves the production and stabilization of an extracellular matrix between cumulus cells surrounding the oocyte. An increase in the expression of the matrix genes HAS2 (Fulop et al., 1997) , TNFAIP6 (Fulop et al., 2003) , PTX3 (Salustri et al., 2004) and PTGS2 (Davis et al., 1999) genes, which are stimulated by gonadotrophins or EGF-like factors, is associated with normal cumulus expansion. In the present study, we observed that stimulation of COCs with AREG did not lead to an increase in the expression of HAS2 and TNFIPA6 when compared with those stimulated with FSH. In particular, HAS2 responded poorly to AREG stimulation. Previous studies in pigs have also shown that cumulus cells of COCs treated with EGF-like factors, such as AREG, had lower expression levels of cumulus expansion-related genes compared with FSH (Prochazka et al., 2011) . Although both FSH and EGF-like factors activate MAPK1/3, PI3K/AKT and MAPK14 pathways via EGFR, EGF-like factors do not mimic all signals elicited by FSH in culture. EGF-like factors do not activate cAMP-PKA and do not stimulate progesterone production, as does FSH (Prochazka et al., 2011) . This could be one of the reasons for the diminished cumulus expansion and lower expression levels of cumulus expansion-related genes in AREGtreated COCs seen in the present study. However, a recent study suggested that a PKA-independent pathway is involved in the regulation of HAS2 expression in cumulus cells (Prochazka et al., 2012) . PKA is not the only transmitter of cAMP signals in mammalian cells (Gerdin and Eiden, 2007) . PKA-independent cAMP signaling has been recently reported in rat granulosa cells via Epac-Rit (Wayne et al., 2007) . Thus, PKA-independent signaling bypassed in AREG stimulation may be associated with the reduced HAS2 expression.
OSFs activate SMAD2/3 and/or SMAD1/5/8 signaling in cumulus cells: an event that is essential for cumulus expansion in the mouse Dragovic et al., 2007) . These events differ markedly in most other species where cumulus expansion is not critically depending on the presence of OSFs (Ralph et al., 1995; Gilchrist and Ritter, 2011) . Consistent with this, in the present study, BMP15 did not increase cumulus expansion of COCs in the absence or presence of FSH or AREG, nor did it alter FSH-or AREG-stimulated expression of genes associated with expansion.
During the ovulatory cascade, cumulus expansion requires glucose, which is converted to UDP-N-acetyl glucosamine via the hexosamine biosynthesis pathway, and is necessary for hyaluronic acid production by HAS2 (Rilla et al., 2013) . Likewise, glucose metabolism via glycolysis in cumulus cells allows for ATP generation. Just as importantly, cumulus cell glycolysis generates metabolites such as pyruvate and lactate that can then be utilized by oocytes, which have a poor capacity to metabolize glucose (Donahue and Stern, 1968; Sutton-McDowall et al., 2010) . Thus cumulus cell glycolysis and glucose consumption have fundamental roles in providing energy and substrates for oocyte metabolism that is necessary for subsequent post-fertilization development. In the present study, both FSH and AREG stimulated glucose uptake and lactate production by COCs, regardless of BMP15 addition. However, glycolysis was stimulated to a greater extent in AREG-treated COCs and furthermore they exhibited a higher ratio of lactate production to glucose consumed compared with the FSH-treated group. This suggests that AREG may stimulate a higher proportion of glucose down the glycolytic pathway, and thereby possibly a reduction of glucose metabolism via the hexosamine biosynthesis pathway, a known 'energy sensing' pathway. Over-stimulation of the hexosamine biosynthetic pathway adversely affects oocyte developmental competence in cattle and pigs (Sutton-McDowall et al., 2006) and in mice, over-stimulation promotes adverse long-term programming effects on fetal development (Schelbach et al., 2010 (Schelbach et al., , 2013 . It is likely that AREG reduces glucose flux through the hexosamine pathway, consistent with both the failure of AREG to stimulate HAS2 expression and the reduced cumulus expansion, thus providing more ATP production from glycolysis within cumulus cells, compared with COCs treated with FSH. We propose this is one mechanism by which AREG improves oocyte developmental competence.
Pyruvate, lactate and glucose that enter the oocyte from cumulus cells via glucose catabolism are metabolized and can provide co-enzymes such as NAD(P)H in the cytosol as well as in the mitochondria (Li et al., 2011) . Activation of the Kreb cycle by uptake of pyruvate in the mitochondria provides more NADH and leads to the reduction of FADH 2 by oxidative phosphorylation via the electron transport chain, which is necessary for ATP production. On the other hand, NADPH from the pentose phosphate pathway reduces oxidized glutathione, a reaction important for maintaining antioxidant defense in the oocyte (de Matos et al., 1997) . Thus, changing the supply of energy substrates entering the oocyte from the cumulus cells should be reflected in levels of NAD(P)H and FAD ++ (Dumollard et al., 2007) . Although AREG increased glucose uptake and glycolysis in COCs, the intensity of NAD(P)H and FAD ++ and the REDOX ratio in oocytes were similar to those observed in the control. However, in the presence of BMP15, their levels were increased by AREG stimulation. This increase in the levels of NAD(P)H and FAD ++ autofluorescence was not observed in denuded oocytes or denuded oocytes co-cultured with COCs upon stimulation with AREG and BMP15. This suggests that AREG increases metabolic activity in the oocyte cooperatively with BMP15 via oocyte-cumulus cell coupling and that these growth factors do not have this effect directly on the oocyte or via paracrine actions from cumulus cells. 
and -, indicate a significant increase and no change to control, respectively; MII, % of oocytes to reach metaphase II; cleaved and ,4 cell, % of cleaved and ,4 cell embryos, respectively; D7BL and D8BL, % of blastocysts at Day 7 and 8 of cleaved embryos, respectively; Hing/Hed, % of hatching/hatched blastocysts of cleaved embryos.
Oocyte-cumulus cell gap-junction coupling is vitally important for oocyte growth and is a key component of oocyte developmental competence . Intercellular communication in COCs can be regulated by dynamic changes in connexin43 (Cx43) and connexin37 (Cx37)-mediated gap-junction communication (GJC) (Sutovsky et al., 1993; Veitch et al., 2004) . Cyclic AMP generated in cumulus cells stimulated by gonadotrophins or forskolin enhances the synthesis of Cx43 and GJC (Thomas et al., 2004; Sasseville et al., 2009) . Furthermore, it is known that FSH positively regulates Cx43-mediated GJC activity through phosphorylation of specific sites via a PKA-dependent pathway (Granot and Dekel, 1994; Yogo et al., 2002 Yogo et al., , 2006 . In contrast to FSH, AREG is not thought to activate cAMP/PKA in cumulus cells (Prochazka et al., 2011) . During the ovulatory cascade, LH-induced expression of AREG and EREG activates cumulus cell EGF receptors, which in turn leads to closure of cumulus-oocyte gap junctions via a MAPK-dependent mechanism (Norris et al., 2008 (Norris et al., , 2010 . These reports are consistent with the present study where we found that FSH but not AREG maintained cumulus-oocyte GJC. Perhaps surprisingly, BMP15 prevented the normal closure of cumulus-oocyte GJC that occurs from 0 to 3 h of oocyte maturation and levels were still elevated by 6 h. This represents a previously undescribed role for BMP15 in oocyte biology. BMP15 even maintained GJC in the presence of AREG, which typically is associated with closure of cumulus-oocyte gap junctions (Norris et al., 2010) . The intracellular mechanism by which BMP15 maintains cumulus-oocyte GJC will be an important issue for future studies. Nonetheless, in the current study, BMP15-enhanced GJC may be an important means by which these oocytes achieve elevated levels of cumulus-derived metabolites that are vital for subsequent embryo development.
In conclusion, the sophisticated communication axes and supply of metabolic substrates between the somatic cells and the germ cell of the COC are central to the oocyte's capacity to support subsequent preimplantation embryo development. Glucose uptake in cumulus cells stimulated by AREG may be utilized for the production of energy via glycolysis rather than being utilized for extracellular matrix and cumulus cell expansion. BMP15 maintains cumulus-oocyte GJC, possibly thereby allowing glycolytic metabolites to be more efficiently transferred to the oocyte from cumulus cells, facilitating oocyte energy production (Fig. 8) . This may be the mechanism by which AREG in combination with BMP15 improves oocyte developmental competence, leading to improved embryo development. This knowledge has significant implications for improving the developmental competence of oocytes derived from IVM for human clinical applications. Figure 8 Hypothesized mechanism by which AREG and BMP15 enhance oocyte developmental competence and ensure subsequent embryo development. HAS2 and TNFIPA6 are efficiently stimulated by FSH but not by AREG. AREG with BMP15 increases TNFIPA6 expression but not HAS2 expression. AREG enhances cumulus cell glucose metabolism via glycolysis compared with FSH but nonetheless leads to somewhat diminished cumulus expansion. Intra-oocyte oxidative phosphorylation is crucial for oocyte developmental competence and the oocyte is dependent on cumulus cells for supply of substrates from metabolized glucose via glycolysis. Accordingly, intra-oocyte NAD(P)H and FAD ++ levels are increased by the combination of AREG and BMP15 but only when cumulus cells and oocytes are physically coupled, which is sustained by BMP15. Thus AREG and BMP15 co-operate to regulate oocyte metabolism by enhancing glycolysis and CC-oocyte gap-junctional communication, which increases oocyte developmental competence and the subsequent development and quality of embryos.
